Nilörngruppen AB (LON:0GB5)
62.90
0.00 (0.00%)
At close: Nov 3, 2025
Nilörngruppen AB Revenue
Nilörngruppen AB had revenue of 230.26M SEK in the quarter ending September 30, 2025, with 10.47% growth. This brings the company's revenue in the last twelve months to 959.83M, up 3.82% year-over-year. In the year 2024, Nilörngruppen AB had annual revenue of 946.48M with 7.81% growth.
Revenue (ttm)
959.83M SEK
Revenue Growth
+3.82%
P/S Ratio
0.69
Revenue / Employee
1.45M SEK
Employees
661
Market Cap
52.67M GBP
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 946.48M | 68.60M | 7.81% |
| Dec 31, 2023 | 877.88M | -70.38M | -7.42% |
| Dec 31, 2022 | 948.27M | 158.02M | 20.00% |
| Dec 31, 2021 | 790.25M | 170.53M | 27.52% |
| Dec 31, 2020 | 619.72M | -96.16M | -13.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |